title: Modifying risks of secondary leukemias: is drug scheduling important?
authors.forename: J E
authors.initials: JE
authors.lastname: Karp
authors.forename: M A
authors.initials: MA
authors.lastname: Smith
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004249:DNA Damage; D004273:DNA, Neoplasm; D004334:Drug Administration Schedule; D006801:Humans; D007938:Leukemia / Q000139:chemically induced* / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000235:genetics; D016032:Randomized Controlled Trials as Topic; D012306:Risk
chemical_list: D000970:Antineoplastic Agents; D004273:DNA, Neoplasm